Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,050.00    50.00 (0.83%)
Bid:
6,035.00
Ask:
6,050.00
Spread: 15.00 (0.249%)
Market Cap: £5.17b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Form 38.5a-DCC PLC

14 May 2026 11:27

RNS Number : 3685E
GoldmanSachs International
14 May 2026
 

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

DCC PLC

Class of relevant security to which the dealings being disclosed relate (Note1)

EUR 0.25 ordinary shares

Date of dealing

13 May 2026

 

2. DEALINGS (Note 2)

(a) Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid (Note 3)

42,712

58.0500 GBP

57.5415 GBP

 

Total number of relevant securities disposed

Highest price received (Note 3)

Lowest price received (Note 3)

52,713

58.0386 GBP

57.5000 GBP

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 4)

Number of relevant securities  (Note 5)

Price per unit  (Note 3)

CFD

Reducing a long position

48

57.7115 GBP

CFD

Increasing a long position

2,342

57.7274 GBP

CFD

Reducing a long position

183

57.8331 GBP

CFD

Increasing a short position

58

57.8500 GBP

CFD

Increasing a short position

9

57.8500 GBP

CFD

Increasing a long position

2,631

57.8502 GBP

CFD

Increasing a short position

3,000

57.8775 GBP

CFD

Increasing a long position

8,078

57.8882 GBP

CFD

Increasing a long position

259

57.8924 GBP

CFD

Increasing a long position

697

57.8924 GBP

CFD

Reducing a long position

667

57.9241 GBP

CFD

Reducing a short position

608

57.9279 GBP

CFD

Reducing a short position

48

57.9396 GBP

CFD

Reducing a short position

98

57.9396 GBP

CFD

Reducing a short position

119

57.9396 GBP

CFD

Reducing a short position

3,583

57.9396 GBP

CFD

Reducing a short position

69

57.9396 GBP

CFD

Reducing a short position

143

57.9396 GBP

CFD

Reducing a short position

33

57.9396 GBP

CFD

Reducing a short position

1,039

57.9464 GBP

CFD

Reducing a short position

30

57.9627 GBP

CFD

Reducing a long position

297

57.9699 GBP

CFD

Increasing a long position

3

57.9833 GBP

CFD

Reducing a long position

169

57.9866 GBP

CFD

Increasing a short position

8

57.9886 GBP

CFD

Increasing a long position

2,282

57.9908 GBP

CFD

Reducing a long position

29

57.9950 GBP

CFD

Reducing a short position

1,425

57.9964 GBP

CFD

Increasing a short position

52

58.0000 GBP

CFD

Reducing a short position

9

58.0000 GBP

CFD

Reducing a short position

173

58.0000 GBP

CFD

Reducing a long position

81

58.0000 GBP

CFD

Reducing a long position

2

58.0000 GBP

CFD

Reducing a long position

3,369

58.0000 GBP

CFD

Increasing a short position

184

58.0035 GBP

CFD

Reducing a long position

190

58.0046 GBP

CFD

Increasing a short position

17

58.0058 GBP

CFD

Increasing a short position

44

58.0086 GBP

CFD

Reducing a long position

42

58.0116 GBP

CFD

Reducing a long position

77

58.0116 GBP

CFD

Reducing a short position

129

58.0386 GBP

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates  (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 3)

 

(ii) Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 3)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 

NONE

 

Date of disclosure

14 May 2026

Contact name

Papa Lette and Andrzej Szyszka

Telephone number

+33(1) 4212 1459 / +48(22) 317 4817

Name of offeree/offeror with which connected

ENERGY CAPITAL PARTNERS, LLC AND KOHLBERG KRAVIS ROBERTS & CO. L. P. (TOGETHER THE "CONSORTIUM")

Nature of connection (Note 6)

Advisor to Offeree

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPZZGMKGDKGVZM
Date   Source Headline
29th May 202011:27 amRNSTotal Voting Rights
28th May 20206:21 pmRNSDirector/PDMR Shareholding
28th May 20201:02 pmRNSHolding in Company TR-1
19th May 20205:04 pmRNSBoard Changes
19th May 20207:00 amRNSResults for the year ended 31 March 2020
14th May 20203:30 pmRNSHolding in Company TR-1
27th Apr 20206:02 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20204:24 pmRNSDirector Declaration
9th Apr 20204:21 pmRNSHolding in Company TR-1
3rd Apr 20204:01 pmRNSHolding in Company TR-1
25th Mar 20203:22 pmRNSHolding in Company TR-1
25th Mar 20207:00 amRNSDCC Healthcare announces acquisition of Amerilab
19th Mar 20204:10 pmRNSHolding in Company TR-1
19th Mar 20209:46 amRNSHolding in Company TR-1
18th Mar 202012:14 pmRNSHolding in Company TR-1
6th Mar 20204:08 pmRNSHolding in Company TR-1
28th Feb 202010:54 amRNSTotal Voting Rights
24th Feb 20208:38 amRNSBoard Change
24th Feb 20208:34 amRNSChief Financial Officer Succession
12th Feb 20209:10 amRNSHolding in Company TR-1
4th Feb 20207:00 amRNSInterim Management Statement
17th Jan 20209:23 amRNSHolding in Company TR-1
3rd Jan 202010:03 amRNSHolding in Company - TR1
23rd Dec 201912:44 pmRNSHolding in Company TR-1
5th Dec 20195:44 pmRNSHolding in Company - TR1
29th Nov 20191:39 pmRNSTotal Voting Rights
27th Nov 20199:18 amRNSDirector Declaration
18th Nov 20196:14 pmRNSDirector/PDMR Shareholding
12th Nov 20197:00 amRNSResults for the six months ended 30 September 2019
12th Nov 20197:00 amRNSDCC Healthcare acquires Ion Laboratories
7th Nov 201911:30 amRNSHolding in Company TR-1
23rd Oct 20192:25 pmRNSHolding in Company TR-1
21st Oct 20195:01 pmRNSHolding in Company TR-1
18th Oct 20194:46 pmRNSHolding in Company TR-1
17th Oct 20199:43 amRNSHolding in Company TR-1
25th Sep 20195:39 pmRNSHolding in Company TR-1
4th Sep 20199:57 amRNSHolding in Company TR-1
9th Aug 201910:42 amRNSHolding in Company TR-1
7th Aug 20199:23 amRNSHolding in Company TR-1
31st Jul 20192:58 pmRNSTotal Voting Rights
16th Jul 20196:14 pmRNSDirector/PDMR Shareholding
12th Jul 20193:06 pmRNSResult of AGM
12th Jul 20197:00 amRNSInterim Management Statement
5th Jul 20199:06 amRNSHolding in Company TR-1
19th Jun 20199:22 amRNSHolding in Company TR-1
13th Jun 201911:37 amRNS2019 Annual Report, Notice of AGM and Proxy Form
31st May 20199:47 amRNSTotal Voting Rights
28th May 20197:00 amRNSHolding in Company TR-1
23rd May 20196:25 pmRNSDirector/PDMR Shareholding
22nd May 20199:43 amRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.